共 50 条
- [42] Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia Antimicrobial Resistance & Infection Control, 11
- [43] Susceptibility of ceftolozane/tazobactam against multidrug-resistant and carbapenem-resistant Pseudomonas aeruginosa NEW MICROBIOLOGICA, 2023, 46 (02): : 213 - 215
- [44] Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis Antimicrobial Resistance and Infection Control, 3
- [45] Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2014, 3
- [46] Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7 MICROBIOLOGY-SGM, 2012, 158 : 1071 - 1083
- [50] Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections ANTIBIOTICS-BASEL, 2023, 12 (12):